Clinical Trial Update: Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome [NA]

View source ↗

Summary

A clinical trial examining angiogenic factors in the development of hepatorenal syndrome (NCT00734136) was terminated by the sponsor (Lahey Clinic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome
• Liver Diseases
• Renal Failure

Snippet

Sponsor: Lahey Clinic | Conditions: Hepatorenal Syndrome, Renal Failure | NA | Status: TERMINATED